Evotec wins $41M R&D contract extension; GSK starts asthma PhIII; Synthetic Biologics raises $10.8M;

Conversation on Twitter :

 @FierceBiotech: Human heart simulated on world's fastest supercomputer. More | Follow @FierceBiotech

 @JohnCFierce: Menarini commits itself to $1B cancer ADC deal with Oxford BioTherapeutics. News | Follow @JohnCFierce

 @RyanMFierce: Five3, maker of cancer genomics software, takes off from UCSC labs. More | Follow @RyanMFierce

> Bayer's Stivarga (regorafenib) gets priority review from FDA for patients with gastrointestinal stromal tumors. News

> Germany's Evotec says that it has extended a research collaboration with the CHDI Foundation, a pact that could be worth up to $41 million in research payments. Release

> GSK ($GSK) says it has launched its Phase III for mepolizumab, an experimental therapy for severe asthma. Release

> Rockville, MD-based Synthetic Biologics has raised $10.8 million in a new financing. Release

> Addex reported positive preclinical data for its experimental therapy aimed at stopping binge drinking. Release

Pharma News

@FiercePharma: Pfizer won't report earnings on Tuesday as planned, thanks to Hurricane Sandy. More | Follow @FiercePharma

> Pfizer reps to bear brunt of Canadian layoffs. Story

> Canada joins in on Novartis vaccine suspension. News

> Docs say they'll wait and see before using biosimilar mAbs. Item

> New AZ chief gets $6.4M to make up for Roche forfeit. Article

Medical Device News

 @FierceMedDev: Hospira faces a Class I recall for its Symbiq infusion system. More | Follow @FierceMedDev

 @MarkHFierce: Drug eluting stents have benefits in people over age 80, acc. to the XIMA study. More | Follow @MarkHFierce

 @DamianFierce: Patheon is spending $255M on softgel specialist Banner Pharmacap. More | Follow @DamianFierce

> Abbott launches massive bond issue to fuel split. Item

> Verax raises $3.3M for blood Dx. News

CRO News

> Patheon buys softgel specialist for $255M. Item

> Small CROs band together to better compete. Story

> Clinipace raises $9M to staff up after acquisition. Article

> Quintiles eyes first global trial for Indonesia. News

Biotech IT News

> Five3, maker of cancer genomics software, takes off from UCSC labs. News

> Human heart simulated on world's fastest supercomputer. Article

> Swedish bioinformatics group grabs $840K to fuel growth, report says. Story

> Accelrys acquisition hunt continues with $30M Aegis deal. Item

And Finally… A regular diet including high levels of flavonoids could reduce a woman's risk of stomach cancer. Story


Suggested Articles

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.